Latest S-1 registration statements
NASDAQ
Fifth District Bancorp adjusts its IPO valuation range following market fluctuations and releases updated financial data.
S-1: Sonnet BioTherapeutics Announces $25 Million Committed Equity Facility with Chardan Capital Markets
Sonnet BioTherapeutics enters into a purchase agreement with Chardan Capital Markets for a committed equity facility of up to $25 million.
OTC.Pink
Scorpius Holdings is undertaking a public offering to raise $11.5 million through the sale of common stock and pre-funded warrants, aiming to bolster working capital and for general corporate purposes.
NASDAQ
TechPrecision Corporation has filed a registration statement for the resale of up to 320,000 shares of its common stock by a selling securityholder, Doerfer Corporation, following the termination of a stock purchase agreement.
NASDAQ
BFRI
Biofrontera INCBiofrontera Inc. has filed a registration statement for the potential resale of up to 11,309,019 shares of common stock by selling stockholders, issuable upon conversion of Series B-3 Convertible Preferred Stock.
NASDAQ
CO2 Energy Transition Corp. details an $800,000 promissory note and files an amendment to its S-1 registration statement for a $60 million initial public offering aimed at the carbon capture and energy transition sector.
S-1/A: Yuenglings Ice Cream Corp. Announces $3 Million Equity Financing Agreement with Trillium Partners
Yuenglings Ice Cream Corporation (YCRM) enters into an equity financing agreement with Trillium Partners, LP for up to $3 million over 24 months, involving the resale of 600,000,000 shares of common stock.
OTC.Pink
S-1/A: Scientific Industries Files Amendment to S-1 Registration for Resale of Common Stock and Warrants
Scientific Industries has filed an amendment to its S-1 registration statement to allow selling stockholders to resell up to 8,035,000 shares of common stock, including shares issuable upon exercise of warrants.
NASDAQ
FB Bancorp, Inc. is offering shares of common stock at $10.00 per share as Fidelity Bank converts from a mutual to a stock form of ownership.
NASDAQ
CETX
Cemtrex INCCemtrex, Inc. has filed a registration statement to offer an additional $1.5 million in units, including securities that underwriters may purchase.
NASDAQ
MOBX
Mobix Labs, INCMobix Labs files an amendment to its registration statement for the resale of up to 9,500,000 shares of Class A Common Stock by B. Riley Principal Capital II.
OTC.Pink
Virpax Pharmaceuticals is seeking to raise capital through an offering of common stock, warrants, and pre-funded warrants, aiming to bolster its financial position and advance its drug development programs.
OQB
Kaival Brands Innovations Group, Inc. announces a best efforts offering of up to $5 million in units to fund operations and working capital, while navigating a complex regulatory landscape for ENDS products.
OQX
Guerrilla RF files an amendment to its S-1 registration statement to allow selling stockholders to resell up to 5,215,086 shares of common stock.
NASDAQ
Churchill Capital Corp IX filed an amendment to its Form S-1 registration statement with the SEC on May 1, 2024, primarily to include an exhibit.
NASDAQ
Nano Nuclear Energy Inc. obtains an exclusive license from Battelle Energy Alliance, LLC for patents related to material transportation devices and systems, aiming to commercially develop these technologies.
AMEX
Kairos Pharma details the terms and conditions for common stock purchase warrants, including exercise price, expiration date, and transfer restrictions, in its latest S-1/A filing.
Organovo Holdings seeks to raise capital through a public offering to fund the clinical development of FXR314 for inflammatory bowel disease and further its 3D tissue technology.
NASDAQ
Beachbody files an amendment to its S-1 registration statement related to the resale of up to 543,590 shares of Class A Common Stock issuable upon exercise of outstanding warrants.
OTC.Pink
Star Alliance International Corp. has filed an amendment to its S-1 registration statement, potentially paving the way for Keystone Capital Partners to purchase up to 75,000,000 shares of its common stock.
NASDAQ
Airship AI Holdings files an amendment to its registration statement for the resale of common stock and warrants by selling securityholders.
NASDAQ
Alpha Cognition Inc. has filed a registration statement for the potential offering and resale of up to 42,676,511 common shares by selling stockholders.
NASDAQ
CETX
Cemtrex INCCemtrex Inc. is offering 5,056,179 units, each consisting of one share of common stock (or a pre-funded warrant), a Series A warrant, and a Series B warrant, to raise capital for operations, marketing, debt repayment, and potential acquisitions.
NASDAQ
Silvaco Group, Inc. files an amended S-1 registration statement detailing changes to its bylaws and preparing for its initial public offering.
NYSE
Sable Offshore Corp. files an amendment to its Form S-1 registration statement, covering the potential resale of up to 67,188,680 shares of common stock and various warrants by selling securityholders.
NASDAQ
Core Scientific files an amendment to its S-1 registration statement for the resale of approximately 10.8 million shares of common stock by selling stockholders following its emergence from Chapter 11 bankruptcy.
NASDAQ
LGVN
Longeveron INCLongeveron has filed a registration statement for the resale of up to 4,967,470 shares of Class A common stock by selling stockholders, primarily stemming from recent warrant exercises.
OTC.Pink
Alternus Clean Energy is registering the resale of up to 35,575,274 shares of common stock by selling securityholders, primarily related to a recent convertible note and warrant issuance, as the company navigates financial challenges and restructuring.
NASDAQ
Waystar Holding Corp. has filed an amendment to its Form S-1 registration statement, outlining the underwriting agreement for its initial public offering of common stock.
NASDAQ
Nano Nuclear Energy Inc. obtains an exclusive license from Battelle Energy Alliance, LLC for patents related to material transportation technology, aiming to commercially develop licensed products.